Glycomet GP 2 mg Tablet – Product Description Glycomet GP 2 mg contains Metformin Hydrochloride Sustained Release and Glimepiride, a combination of medicines used to help control high blood sugar levels in adults with Type 2 diabetes mellitus. Metformin helps reduce glucose production by the liver and improves the body's response to insulin, while Glimepiride helps the pancreas release insulin and lower blood glucose. The sustained-release formulation is designed to provide prolonged action and support convenient blood sugar management when prescribed by a healthcare professional. Glycomet GP should be taken strictly according to the prescribed dose and schedule. Regular monitoring of blood glucose, along with a balanced diet and appropriate physical activity, is generally recommended as part of diabetes management. Key Benefits: Helps control elevated blood glucose levels in Type 2 diabetes. Combines the actions of Metformin and Glimepiride. Sustained-release formulation for prolonged medication action. Supports improved blood sugar control when used as prescribed. Important: This medicine may cause low blood sugar, particularly if meals are skipped or the prescribed dose is exceeded. Use only under medical supervision and follow your doctor's instructions regarding dosage, diet, and blood-glucose monitoring.